MedTrace Logo

The Effect of NHE and KT on the Hamstring Strength and Sprint Performance in Collegiate Sprinters

NCT05496660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-11

No results posted yet for this study

Summary

The invesitgators performed a randomized controlled trial on collegiate sprinters to explore the combined effect of the NHE and KT and randomly allocated the subjects into the experimental (NHE+KT) or control (NHE) group by an independent researcher using the sealed envelopes method.

To calculate the sample size, a Cohen's d effect size of 0.4, an alpha level of 0.05, a test power of 0.95 were configured to G\*Power software, at least 34 samples were computed. Considering the dropouts, 40 male collegiate sprinters were enrolled, explained the procedures of this study and voluntarily written informed consent. Inclusion criteria was that participants must be male, aged 18 years or older, training at the university level at least 4 times per week, with no history of lower limb injury within the last 6 months and no previous experience of the NHE or KT. Participants who had lower limb mobility limitation or injury especially HSI within 6 months and associated musculoskeletal, respiratory or cardiovascular diseases and was allergic to kinesio tape were excluded.

Conditions

  • Hamstring Injury

Interventions

OTHER

NHE+KT

the Nodic hamstring exercise plus the kinesio taping with tension during 4-week consisting 12 sessions

OTHER

NHE

the Nodic hamstring exercise plus the kinesio taping without tension during 4-week consisting 12 sessions

Sponsors & Collaborators

  • Tianjin University of Sport

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-03-31
Completion
2022-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05496660 on ClinicalTrials.gov